Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127426 trials found · Page 1576 of 6372
-
New study aims to catch heart risks early in cancer treatment
Knowledge-focused Recruiting nowThis study will prospectively monitor cancer patients receiving chemotherapy (including molecular targeted therapies) for cardiovascular adverse events using biomarkers and imaging. The goal is to develop a predictive model for major adverse cardiovascular events (MACE) in this p…
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
AR goggles join the fight against PTSD in veterans
Symptom relief Recruiting nowThe goal of this trial is to test how augmented reality exposure therapy (ARET) may potentiate the effects of traditional exposure therapy administered to U.S. military personnel diagnosed with PTSD. 40 adult males and females over the age of 18 that have served, or are currently…
Sponsor: Wayne State University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New hope for liver cancer: drug targets tumors resistant to immunotherapy
Disease control Not yet recruiting1. To investigate the efficacy and safety of cabozantinib in patients with progressive HCC after ICI-based combination treatment. 2. To explore potential tissue and peripheral blood biomarkers associated with clinical benefits of cabozantinib, and resistance mechanisms of prior I…
Phase 2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Jun 26, 2026 12:37 UTC
-
New hope for stomach cancer: Real-World study explores better Second-Line treatments
Disease control Recruiting nowThis study is an open-label, multi-cohort real-world research that explores the efficacy and safety of different second-line treatment regimens for gastric/gastroesophageal junction adenocarcinoma that has failed first-line fluoropyrimidine, platinum-based chemotherapy combined w…
Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New blood thinner may beat aspirin for aneurysm patients
Disease control Recruiting nowThis project aims to evaluate the safety and efficacy of the antiplatelet regimen combining indobufen and clopidogrel in preventing ischemic events after stent-assisted coiling embolization and flow diverter implantation for intracranial aneurysms. Using a randomization system, …
Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New ultrasound technique could spot deadly varices without a scope
Diagnosis Recruiting nowTo evaluate the diagnostic value of the combined model of subharmonic-assisted pressure estimation (SHAPE), liver stiffness (LSM), and platelet count (PLT) for high-risk esophageal and gastric varices (HRV)
Sponsor: The First Hospital of Jilin University • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Do Younger-Age pancreatic tumors behave differently? a new study digs in
Knowledge-focused Recruiting nowThe aim of this observational multicenter retrospective cohort study is to evaluate the differences in risk factors, prognosis, clinicopathological and metabolic characteristics between early-onset pancreatic neuroendocrine tumors (EO-PanNETs) and late-onset pancreatic neuroendoc…
Sponsor: Qilu Hospital of Shandong University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Could a vitamin B12 shot help kids with MMA? new trial underway
Disease control Not yet recruitingThis study is a Single-Center, Single-Arm, open-label, Phase III clinical study to evaluate the efficacy, safety characteristics of Hydroxocobalamin Chloride Injection (20 mg/mL) for Maintenance Therapy in participants with Methylmalonic Acidemia (MMA) with Elevated Homocysteine …
Phase 3 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 14:49 UTC
-
Could common antioxidants help thalassemia patients?
Disease control Not yet recruitingThe current study is to investigate the potential roles of N-acetyl cysteine and Alpha-lipoic acid in patients with beta-thalassemia.
Phase 3 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 26, 2026 14:23 UTC
-
Socks against side effects: simple stockings may shield nerves during chemo
Prevention Recruiting nowThis multicenter, prospective phase II clinical trial aims to evaluate the efficacy and safety of medical compression stockings in preventing peripheral neuropathy induced by antibody-drug conjugates (ADCs) containing monomethyl auristatin E (MMAE) in patients with advanced cance…
Sponsor: Sheng Zhang • Aim: Prevention
Last updated Jun 26, 2026 16:56 UTC
-
Could a probiotic protect pregnant women and their babies from gut damage?
Disease control Recruiting nowBurden: Environmental Enteric Dysfunction (EED) is an enteropathic condition characterised by altered gut permeability, infiltration of immune cells, and changes in villous architecture and cell differentiation. EED is a major reason of malnourishment, poor neurological developme…
Phase 2 • Sponsor: Aga Khan University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could a single drug infusion limit permanent heart damage during a heart attack?
Disease control CompletedThis Phase Ila trial evaluates whether the intravenous administration of Dexrazoxane can reduce permanent heart muscle damage in patients undergoing standard stent procedures (PCI) for a severe heart attack (STEMI).
Phase 2 • Sponsor: Rohan Dharmakumar • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Gene therapy for rare heart disease passes early safety check
Disease control By invitation onlyThe primary objective of this Phase 1/2 long-term follow-up (LTFU) study is to assess the long-term safety and tolerability of LX2020 for the treatment of arrhythmogenic cardiomyopathy (ACM) due to a plakophilin-2 gene (PKP2) pathogenic variant (PKP2-ACM).
Sponsor: Lexeo Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could a simple amino acid ease GRIN disorder symptoms? new trial aims to find out.
Disease control Recruiting nowThe goal of this clinical study is to find out whether L-serine dietary supplementation helps improve overall clinical functioning in children and young adults (2-30 years) with GRIN-related neurodevelopmental disorders (GRIN-NDD) caused by loss-of-function (LoF) variants in GRIN…
Phase 3 • Sponsor: Meyer Children's Hospital IRCCS • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Bladder cancer breakthrough? MRI may predict chemo success in days
Diagnosis Recruiting nowBladder cancer is a prevalent malignancy globally, with muscle-invasive disease having a five-year survival rate below 50%. Neoadjuvant chemotherapy (NAC) before radical cystectomy has shown efficacy for resectable muscle-invasive bladder cancer (MIBC). However, non-response to N…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 27, 2026 07:52 UTC
-
Supercharged immune cells take on advanced cancers
Disease control Recruiting nowA Study of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) Therapy for Patients With Advanced Solid Tumors
Early phase 1 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:55 UTC
-
Quick chagas tests could speed up diagnosis in argentina
Diagnosis Recruiting nowChagas disease (CD) is the most significant endemic zoonosis in Argentina. Two-thirds of affected individuals live in urban areas but only 10% globally are aware of their infection. Diagnosing Chronic Chagas (CCD) requires at least two serological tests, often limited to referenc…
Sponsor: Instituto Nacional de Parasitologia Dr. Mario Fatala Chaben • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
Aspirin may shield cancer patients from deadly clots during chemo
Prevention Recruiting nowThe purpose of this study is to the 6-month Venous Thromboembolism (VTE)-free rate in participants with advanced germ cell cancer at high risk of VTE who are receiving standard of care cisplatin-based chemotherapy and low-dose acetylsalicylic acid (ASA) and compare to relevant hi…
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Prevention
Last updated Jul 26, 2026 00:00 UTC
-
New drug targets rare gene fault in advanced cancers
Disease control Recruiting nowThe goal of this clinical study is to learn more about the study drug, GS-5319, its dosing, safety and tolerability when given as a single medication and as a combined medication in adults with solid tumors, where the participants show a specific gene alteration in the tumor. The…
Phase 1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can two cancer pills keep breast cancer from returning?
Disease control Recruiting nowTo evaluate the efficacy and safety of adjuvant CDK4/6 inhibitors in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer.
Sponsor: Wenjin Yin • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC